Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research
Best Sites For Most Accurate CGM Readings
Benefits of Using GLP-1 Receptor Agonists in Type 2 Patients
Cost Benefit Analysis of Human and Analog Insulin
MOST POPULAR ARTICLES OF THE MONTH
#1 Updated Consensus Report on Diabetic Nutrition Therapy
#2 First Major Breakthrough In 20 Years For The Treatment of Diabetic Kidney Disease and Heart Failure
#3 FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes, But Wait!
Editor's Note
Last week I was watching an episode of the show New Amsterdam and they had an ER patient who was in DKA because they couldn’t afford their insulin. The medical director made a big deal and said they would make their own. The first thing that came to my mind was a $25 bottle of regular insulin and a $25 bottle of NPH from Walmart, and how for $50 to $75 a month a patient could manage their diabetes.
When I presented this to my interns they gave me every reason why this wouldn’t work, but one intern, Adam Chalela B.S., PharmD Candidate, USF College of Pharmacy Class of 2020, brought us some information proving that the $75 treatment works.
Dave Joffe
Editor-in-chief
TOP STORIES -- Diabetes News and Research
Which sites of continuous monitoring provide the most accurate, sensitive, and specific real-time values of blood glucose?
The use of GLP-1 receptor agonists in patients may prevent multiple risks.
Rising insulin costs have created limiting barriers in diabetic therapy plans. A recent study provides data on which insulin types may be the most cost-effective.
About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.